Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06205589
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-01-04
Brief Title:
Therapeutic ID93 GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
Sponsor:
Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections
Organization:
Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections
Organization Data
Organization:
Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections
Class:
NETWORK
Study ID:
ACTG A5397
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Institute of Allergy and Infectious Diseases NIAID | NIH |